Research and analysis

NERVTAG: At what point might meaningful results from clinical trials be available?, 30 March 2020

Paper prepared by the New and Emerging Respiratory Virus Threats Advisory Group (NERVTAG) for the Scientific Advisory Group for Emergencies (SAGE).

• From: Scientific Advisory Group for Emergencies
• Published: 19 June 2020

Documents

At what point might meaningful results from clinical trials be available? - 30 March 2020

PDF, 117 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email contact@go-science.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Paper by NERVTAG on meaningful results from clinical trials. It was considered at SAGE 21 on 31 March 2020.

It should be viewed in context: the paper was the best assessment of the evidence at the time of writing. The picture is developing rapidly and, as new evidence or data emerges, SAGE updates its advice accordingly. Therefore, some of the information in this paper may have been superseded and the author’s opinion or conclusion may since have developed.

These documents are released as pre-print publications that have provided the government with rapid evidence during an emergency. These documents have not been peer-reviewed and there is no restriction on authors submitting and publishing this evidence in peer-reviewed journals.

Redactions within this document have been made to remove any security markings.

Published 19 June 2020